Cannabix Technologies
Receives Positive Testing Certification
for Breath Logix Autonomous Alcohol Breathalyzer
Cannabix has developed an
autonomous alcohol breathalyzer screening device for employers and
a range of industries and safety settings
Vancouver, British Columbia, Canada -- November 26, 2024 --
InvestorsHub NewsWire -- Cannabix Technologies Inc. (CSE:
BLO) (OTC
PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”)
developer of marijuana and alcohol breath testing devices is
pleased to report that it has received a positive certification
test report from globally recognized laboratory, CEcert GmbH, based
in Germany (“CEcert”), for its Breath Logix autonomous wall mounted
alcohol breathalyzer device (Figure 1). The certification is
a prerequisite for the Company’s Australian distributor and opens
the pathway for marketing and sales of devices in other
jurisdictions. The Breath Logix product, which has several
innovative features, is targeted to employers, alcohol testing
facilities and a range of safety settings, including mining, oil
and gas, industrial, trucking, warehousing and technology.
Hightlights:
- Cannabix has received a positive certification test report from
CEcert GmbH (Germany) for its Breath Logix autonomous wall mounted
alcohol breathalyzer device.
- The positive certification test report is a major milestone for
the Company and provides a pathway for sales and marketing in
Australia and other jurisdictions.
- The Breath Logix devices were tested under the Australian
Standard AS 3547.1 (for electronic breath alcohol testing
devices for professional use requirements and test methods)
--one of the world’s most comprehensive alcohol testing standard
protocols. Devices were tested for over 6-months under rigorous
alcohol, drift, climatic, electromagnetic compatibility (EMC) and
vibration testing.
- Cannabix is working with an Australian alcohol device
distributor, targeting various employers, alcohol testing
facilities and a range of other safety settings including mining,
oil and gas, industrial, trucking, warehousing and technology.
- Cannabix is quickly advancing both its marijuana breathalyzer,
with key validation work underway, and its Breath Logix technology
with completion of CEcert standards testing.
Ben Smit, Managing Director of Breathalyser Sales & Service
Pty Ltd., stated, “The ability of the Cannabix team to
develop the Breath Logix device and pass rigorous testing applied
by CEcert is truly impressive in such a condensed period of time.
Furthermore, the Australian Standard for alcohol testing is a very
high bar to cross. With the passing of the CEcert testing, we can
now move quickly with Australian regulators to have the devices
locally certified. We are thrilled to be working with Cannabix to
bring this new product to market. Autonomous employee alcohol
screening is a major segment of our business and we welcome
innovative products like the Breath Logix device.”
The Company proceeded with AS 3547.1 testing in order to pursue
the alcohol device market in Australia and in several countries.
Cannabix has been working with Breathalyser Sales & Service Pty
Ltd., (“Breathalyser SSP”) in preparation of marketing and sales in
the region. Pre-access alcohol testing (using wall mounted devices)
is common across a range of industries in Australia, New Zealand
and South Africa including mining, oil and gas, industrial,
trucking, warehousing and technology. The Company expects to begin
marketing the device in the United States, Canada and in Europe
shortly, further updates on this front will be provided.
Breathalyser SSP is a leading distributor of alcohol and drug
testing devices for employers and personal use, offering well
established alcohol product lines like Draeger and
AlcoMeasure for the Australian market. Breathalyser SSP
will procced to submit the Breath Logix device to Australian
regulators, for country certification, now that the CEcert testing
has been cleared.
Figure 1. Breath Logix Autonomous Alcohol Testing
System
Figure 2. Breath Logix in use with straw. Contactless
breath test mode also available.
Figure 3. Breath Logix (compact version). Contactless
and straw mode both available.
Breath Logix Features
The Breath Logix device hosts a number of features including
patent pending pre-calibrated cartridge technology (See Figure 4)
which will allow administrators to easily maintain their devices,
and eliminate the need for costly calibration equipment and
time-consuming site visits from technicians for maintenance.
This device can be used for pre-access alcohol testing,
random testing, start-of-shift testing, pre-employment testing,
return-to-work testing and post-incident testing.
The Breath Logix autonomously checks the sobriety of a user and
can take a picture to confirm and record identity while a breath
sample is being delivered. Upon detection of positive breath
alcohol result, the device will deliver a precise Blood Alcohol
Content (BAC) level on the screen, and send a real-time test report
via text message, e-mail and to a dedicated web portal.
Furthermore, the system logs user test reports for incident
reporting and historical investigations.
For example, under the 24/7 Sobriety Program (deployed
in several US states to reduce the re-arrests of individuals
previously convicted of driving while under the influence of
alcohol through daily breath testing) the Breath Logix is currently
helping the Friedel Clinic (Montana) save money, time and resources
by autonomously collecting breath samples from clients on a daily
basis, eliminating the need for dedicated in-house alcohol
screening administrators using conventional handheld devices.
Figure 4. Breath Logix pre-calibrated alcohol sensor
cartridge technology
About Cannabix Technologies Inc.
Cannabix Technologies Inc. is a developer of marijuana and
alcohol breathalyzer technologies for law enforcement, workplaces
and laboratories. Cannabix is developing delta-9 THC and alcohol
screening devices. Delta-9 THC is the primary psychoactive
ingredient in cannabis. Breath testing for delta-9 THC would allow
employers and law enforcement to identify recent marijuana
use. Cannabix is the developer of its Breath Logix Series of
breath alcohol detection devices for employers and a range of
other settings.
We seek Safe Harbor.
On behalf of the Board of Directors
“Rav Mlait”
CEO
Cannabix Technologies Inc.
For further information, contact the Company at info@cannabixtechnologies.com
The CSE has not reviewed and does not accept responsibility
for the adequacy or accuracy of this release.
Cautionary Statement Regarding Forward-Looking Statements
This news release contains certain "forward-looking statements"
within the meaning of such statements under applicable securities
law. Forward-looking statements are frequently characterized by
words such as "anticipates," "plan," "continue," "expect,"
"project," "intend," "believe," "anticipate," "estimate," "may,"
"will," "potential," "proposed," "positioned" and other similar
words, or statements that certain events or conditions "may" or
"will" occur. Forward-looking statements in this news release
include, but are not limited to, statements relating to:
certification of devices, acceptance of devices by international
regulators, the achievement of any or all of the goals and aims of
the strategic partnership and development agreement with
Omega Laboratories; the completion of pre-validation or validation
testing described in this news release; final development of a
commercial or prototype product(s); the successful trial or pilot
of company technologies; the commercialization of the Company's
products; the negotiation and potential entry into additional
agreements with distributors; and the completion of future
financings. There are numerous risks and uncertainties that could
cause actual results and the Company’s plans and objectives to
differ materially from those expressed in the forward-looking
information. Important factors that could cause actual results to
differ materially from those expressed in the forward-looking
information include (but are note limited to): adverse market
conditions; risks regarding protection of proprietary technology;
the ability of the Company to complete future financings; the
ability of the Company to develop and market its future product;
risks regarding government regulation, managing and maintaining
growth, the effect of adverse publicity, litigation, competition;
that Omega may not complete all or any of the milestones as
contemplated strategic partnership and development agreement with
Omega Laboratories; that the CSE may not approve the issuance of
the securities; that the Company’s development of breathalyzer
technology will provide any benefit to the Company; there is no
assurance that any proposed new products will be built, will be
successful in beta testing or clinical trials; there is no
assurance that the Company will enter into any partnerships to
advance any of its corporate initiatives or technologies; there is
no assurance that any “patent pending” or “provisional patents”
technologies licensed by the Company or owned by the Company will
receive patent status by regulatory authorities; the Company is not
currently selling breathalyzers and there is no assurance that the
Company ever will; and other factors beyond the control of the
Company. Actual results and future events could differ materially
from those anticipated in such information. These and all
subsequent written and oral forward-looking information are based
on estimates and opinions of management on the dates they are made
and are expressly qualified in their entirety by this notice.
Except as required by law, the Company does not intend to update
these forward-looking statements.
501-3292 Production Way, Burnaby, B.C., V5A 4R4
Phone: (604) 551-7831 Fax:
604-676-2767
info@cannabixtechnologies.com
cannabixtechnologies.com
Cannabix Technologies (PK) (USOTC:BLOZF)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Cannabix Technologies (PK) (USOTC:BLOZF)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
